Viewing Study NCT00506402


Ignite Creation Date: 2025-12-25 @ 4:03 AM
Ignite Modification Date: 2026-02-28 @ 2:10 AM
Study NCT ID: NCT00506402
Status: COMPLETED
Last Update Posted: 2009-05-05
First Post: 2007-07-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Study of MKC-1 in Patients With Refractory Hematologic Malignancies
Sponsor: CASI Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module